HTG MOLECULAR DIAGNOSTICS (HTGM) Stock Cash Flow
NASDAQ:HTGM - Nasdaq - US40434H3021 - Common Stock - Currency: USD
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.15M | -21.59M | -17.15M | -20.87M | -19.30M | |||
| Depreciation Amortization | 487.75K | 587.14K | 721.25K | 1.35M | 1.26M | |||
| Change In Working Capital | -175.26K | -139.01K | -1.01M | -230.00K | -810.00K | |||
| Interest Paid | 412.76K | 477.63K | 599.92K | 870.00K | 690.00K | |||
| Taxes Paid | 10.81K | 8.97K | 12.67K | 20.00K | 0.00 | |||
| Other non cash items | 3.01M | 2.74M | 930.14K | 3.46M | 2.15M | |||
| OPERATING CASH FLOW | -16.83M | -18.41M | -16.51M | -16.29M | -16.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -20.86K | -23.04K | -644.38K | -450.00K | -1.10M | |||
| Other Investing Activity | 3.50M | 12.44M | -6.02M | 19.18M | -2.40M | |||
| INVESTING CASH FLOW | 3.48M | 12.42M | -6.66M | 18.73M | -3.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.80M | -7.44M | -1.30M | -90.00K | -1.37M | |||
| Stock Issued/Repurchased | -169.85K | 7.04M | 900.31K | 1.57M | 20.88M | |||
| Other Financing Activity | 8.70M | 9.00M | 10.79M | 7.57M | -120.00K | |||
| FINANCING CASH FLOW | 1.73M | 8.60M | 10.39M | 9.05M | 19.39M | |||
| Exchange Rate Effect | 1.08K | -6.36K | -16.19K | 20.00K | 0.00 | |||
| CHANGE IN CASH | -11.62M | 2.61M | -12.80M | 11.51M | -810.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.83M | -18.41M | -16.51M | -16.29M | -16.70M | |||
| Capital Expenditure | -20.86K | -23.04K | -644.38K | -450.00K | -1.10M | |||
| FREE CASH FLOW | -16.85M | -18.43M | -17.15M | -16.74M | -17.80M | |||
All data in USD